tiprankstipranks
Trending News
More News >
Carl Zeiss Meditec (DE:AFX)
:AFX
Germany Market
Advertisement

Carl Zeiss Meditec (AFX) Ratios

Compare
90 Followers

Carl Zeiss Meditec Ratios

DE:AFX's free cash flow for Q2 2025 was €0.54. For the 2025 fiscal year, DE:AFX's free cash flow was decreased by € and operating cash flow was €0.13. See a summary of the company’s cash flow.
Ratios
TTM
Sep 24Sep 23Sep 22Sep 21
Liquidity Ratios
Current Ratio
2.04 3.40 3.32 3.58 4.34
Quick Ratio
1.17 2.48 2.61 2.94 3.38
Cash Ratio
0.04 0.02 0.01 0.02 0.02
Solvency Ratio
0.12 0.42 0.46 0.41 0.32
Operating Cash Flow Ratio
0.26 0.45 0.35 0.81 0.60
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 9.15
Net Current Asset Value
€ -100.00M€ 1.05B€ 999.13M€ 885.43M€ 730.02M
Leverage Ratios
Debt-to-Assets Ratio
0.04 0.05 0.05 0.05 0.03
Debt-to-Equity Ratio
0.07 0.07 0.06 0.07 0.05
Debt-to-Capital Ratio
0.07 0.07 0.06 0.07 0.05
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.04 0.06
Financial Leverage Ratio
1.67 1.40 1.40 1.44 1.41
Debt Service Coverage Ratio
-18.97 25.06 39.07 32.85 4.45
Interest Coverage Ratio
-26.22 21.45 43.06 37.20 7.41
Debt to Market Cap
0.00 0.00 0.00 <0.01 0.01
Interest Debt Per Share
1.56 1.91 1.54 1.46 1.08
Net Debt to EBITDA
0.48 0.29 0.25 0.28 0.24
Profitability Margins
Gross Profit Margin
52.43%57.71%59.26%58.73%55.83%
EBIT Margin
10.91%20.48%21.71%21.16%15.47%
EBITDA Margin
11.47%24.06%25.35%24.85%19.95%
Operating Profit Margin
12.82%15.66%21.71%21.16%15.47%
Pretax Profit Margin
9.42%19.75%21.20%20.59%13.38%
Net Profit Margin
7.19%13.90%15.45%14.35%9.16%
Continuous Operations Profit Margin
7.23%13.98%15.55%14.42%9.24%
Net Income Per EBT
76.32%70.39%72.84%69.69%68.48%
EBT Per EBIT
73.42%126.11%97.68%97.31%86.50%
Return on Assets (ROA)
4.49%9.57%10.41%9.86%6.08%
Return on Equity (ROE)
7.53%13.45%14.59%14.24%8.55%
Return on Capital Employed (ROCE)
9.78%13.24%18.09%17.89%12.04%
Return on Invested Capital (ROIC)
7.44%9.29%13.14%12.41%8.15%
Return on Tangible Assets
8.73%12.32%13.65%12.35%7.94%
Earnings Yield
3.46%3.92%3.06%1.59%1.27%
Efficiency Ratios
Receivables Turnover
3.66 234.17 1.39 1.27 -1.34K
Payables Turnover
5.46 3.68 4.10 4.67 6.43
Inventory Turnover
1.87 1.70 2.03 2.37 2.06
Fixed Asset Turnover
6.09 6.62 8.06 8.25 9.87
Asset Turnover
0.62 0.69 0.67 0.69 0.66
Working Capital Turnover Ratio
6.42 1.61 1.58 1.53 1.36
Cash Conversion Cycle
227.72 117.41 353.24 362.64 120.18
Days of Sales Outstanding
99.69 1.56 262.11 286.95 -0.27
Days of Inventory Outstanding
194.88 214.91 180.21 153.81 177.17
Days of Payables Outstanding
66.84 99.06 89.07 78.13 56.72
Operating Cycle
294.57 216.47 442.31 440.76 176.90
Cash Flow Ratios
Operating Cash Flow Per Share
1.91 2.80 2.10 4.05 2.00
Free Cash Flow Per Share
1.22 1.53 1.19 3.32 1.49
CapEx Per Share
0.69 1.27 0.92 0.74 0.50
Free Cash Flow to Operating Cash Flow
0.64 0.55 0.56 0.82 0.75
Dividend Paid and CapEx Coverage Ratio
1.48 1.18 1.16 3.27 1.73
Capital Expenditure Coverage Ratio
2.76 2.20 2.30 5.49 3.97
Operating Cash Flow Coverage Ratio
1.13 1.61 1.47 2.99 2.60
Operating Cash Flow to Sales Ratio
0.08 0.12 0.10 0.22 0.13
Free Cash Flow Yield
2.35%1.85%1.11%2.00%1.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
28.88 25.51 32.70 62.86 78.93
Price-to-Sales (P/S) Ratio
2.08 3.55 5.05 9.02 7.23
Price-to-Book (P/B) Ratio
2.17 3.43 4.77 8.95 6.75
Price-to-Free Cash Flow (P/FCF) Ratio
42.58 54.07 90.47 50.08 72.33
Price-to-Operating Cash Flow Ratio
27.05 29.53 51.07 40.95 54.11
Price-to-Earnings Growth (PEG) Ratio
-1.51 -20.98 1.33 0.68 -3.36
Price-to-Fair Value
2.17 3.43 4.77 8.95 6.75
Enterprise Value Multiple
18.66 15.02 20.17 36.57 36.50
Enterprise Value
4.64B 7.55B 9.73B 14.97B 9.72B
EV to EBITDA
18.66 15.02 20.17 36.57 36.50
EV to Sales
2.14 3.61 5.11 9.09 7.28
EV to Free Cash Flow
43.71 55.13 91.60 50.46 72.81
EV to Operating Cash Flow
27.88 30.11 51.70 41.27 54.46
Tangible Book Value Per Share
4.61 16.74 15.21 13.36 10.95
Shareholders’ Equity Per Share
23.81 24.14 22.53 18.55 16.01
Tax and Other Ratios
Effective Tax Rate
0.23 0.29 0.27 0.30 0.31
Revenue Per Share
24.89 23.36 21.27 18.41 14.93
Net Income Per Share
1.79 3.25 3.29 2.64 1.37
Tax Burden
0.76 0.70 0.73 0.70 0.68
Interest Burden
0.86 0.96 0.98 0.97 0.87
Research & Development to Revenue
0.15 0.17 0.15 0.14 0.16
SG&A to Revenue
0.06 0.04 0.04 0.04 0.04
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
2.10 0.86 0.64 1.53 1.45
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis